Organogenesis Holdings Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Organogenesis Holdings Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2018 to Q2 2024.
  • Organogenesis Holdings Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $834K, a 32.1% decline year-over-year.
  • Organogenesis Holdings Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $4.19M, a 14.4% decline year-over-year.
  • Organogenesis Holdings Inc. annual Amortization of Intangible Assets for 2023 was $4.92M, a 0.72% increase from 2022.
  • Organogenesis Holdings Inc. annual Amortization of Intangible Assets for 2022 was $4.88M, a 1.33% decline from 2021.
  • Organogenesis Holdings Inc. annual Amortization of Intangible Assets for 2021 was $4.95M, a 32.2% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.19M $834K -$395K -32.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.59M $901K -$329K -26.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.92M $1.23M +$8K +0.66% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $4.91M $1.23M +$10K +0.82% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.9M $1.23M +$8K +0.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $4.89M $1.23M +$9K +0.74% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $4.88M $1.22M -$2K -0.16% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.89M $1.22M -$20K -1.61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.91M $1.22M -$22K -1.77% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.93M $1.22M -$22K -1.77% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $4.95M $1.22M -$4K -0.33% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $4.95M $1.24M +$355K +40.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $4.6M $1.24M +$427K +52.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.17M $1.24M +$426K +52.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.75M $1.23M -$290K -19.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $4.04M $885K -$644K -42.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $4.68M $816K -$683K -45.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $5.36M $817K -$681K -45.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $6.04M $1.52M +$600K +65.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $5.44M $1.53M +$611K +66.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $4.83M $1.5M +$582K +63.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $4.25M $1.5M +$581K +63.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $3.67M $917K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 $918K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $917K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $917K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.